These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4008262)

  • 1. Population doses, excess deaths and loss of life expectancy from mass chest x-ray examinations in Japan--1980.
    Kumamoto Y
    Health Phys; 1985 Jul; 49(1):37-48. PubMed ID: 4008262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimations of organ dose and health risk of the mass chest X-ray examinations in children].
    Ohta K; Takamoto M; Kai M; Kusama T; Aoki Y
    Nihon Koshu Eisei Zasshi; 1993 Jun; 40(6):475-81. PubMed ID: 8347863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer mortality in women after repeated fluoroscopic examinations of the chest.
    Boice JD; Monson RR; Rosenstein M
    J Natl Cancer Inst; 1981 May; 66(5):863-7. PubMed ID: 6939930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective dose equivalent and associated risks from mass chest radiography in Kuwait.
    Mustafa AA; Kouris K
    Health Phys; 1985 Dec; 49(6):1147-54. PubMed ID: 4077516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
    Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
    Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of benefit and radiation risk from mass chest radiography.
    Kitabatake T; Yokoyama M; Sakka M; Koga S
    Radiology; 1973 Oct; 109(1):37-40. PubMed ID: 4805835
    [No Abstract]   [Full Text] [Related]  

  • 7. A framework for estimating radiation-related cancer risks in Japan from the 2011 Fukushima nuclear accident.
    Walsh L; Zhang W; Shore RE; Auvinen A; Laurier D; Wakeford R; Jacob P; Gent N; Anspaugh LR; Schüz J; Kesminiene A; van Deventer E; Tritscher A; del Rosarion Pérez M
    Radiat Res; 2014 Nov; 182(5):556-72. PubMed ID: 25251702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESTIMATION OF FEMALE RADIATION DOSES AND BREAST CANCER RISK FROM CHEST CT EXAMINATIONS.
    Lahham A; ALMasri H; Kameel S
    Radiat Prot Dosimetry; 2018 Jun; 179(4):303-309. PubMed ID: 29237054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of population doses from medical uses of radiopharmaceuticals in Japan, 1977. 2. Estimation of genetically significant dose, per caput mean bone marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Maruyama T; Yamaguchi H; Nishizawa K; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Jul; 39(7):747-60. PubMed ID: 492934
    [No Abstract]   [Full Text] [Related]  

  • 10. The assessment of late effects on a population exposed to activity released into the environment.
    Reissland JA; Kay P
    Phys Med Biol; 1977 Nov; 22(6):1168-79. PubMed ID: 594146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 3. Per caput mean marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976 Mar; 36(3):216-24. PubMed ID: 1066648
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiographic screening of infants and young children with genetic predisposition for rare malignancies: DICER1 mutations and pleuropulmonary blastoma.
    Sabapathy DG; Guillerman RP; Orth RC; Zhang W; Messinger Y; Foulkes W; Priest JR; Annapragada AV
    AJR Am J Roentgenol; 2015 Apr; 204(4):W475-82. PubMed ID: 25794098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concept of malignant significant factor and its applicability for medical and occupational exposures (author's transl)].
    Hashizume T; Maruyama T; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 Aug; 40(8):815-22. PubMed ID: 7433009
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age.
    Zacharatou Jarlskog C; Paganetti H
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):228-35. PubMed ID: 18571337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation exposure and estimate of late effects of chest roentgen examination in children.
    Gustafsson M; Mortensson W
    Acta Radiol Diagn (Stockh); 1983; 24(4):309-14. PubMed ID: 6637569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fitting the Armitage-Doll model to radiation-exposed cohorts and implications for population cancer risks.
    Little MP; Hawkins MM; Charles MW; Hildreth NG
    Radiat Res; 1992 Nov; 132(2):207-21. PubMed ID: 1438703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimates of lifetime lung cancer risks resulting from Rn progeny exposure.
    Thomas DC; McNeill KG; Dougherty C
    Health Phys; 1985 Nov; 49(5):825-46. PubMed ID: 2999034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical irradiation in Japan - stochastic risk estimation and its reduction (author's transl)].
    Hashizume T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 May; 41(5):445-74. PubMed ID: 7301534
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to assess natural risks.
    Sakka M
    J Radiat Res; 1982 Dec; 23(4):411-22. PubMed ID: 7182492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.